Advisor Group Holdings, Inc. Akebia Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,774 shares of AKBA stock, worth $31,173. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,774

Previous 5,000 195.48%

Holding current value

$31,173

Previous $18,000 194.44%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$1.55 - $3.97 $15,149 - $38,802	9,774 Added 195.48%	14,774 $53,000
Q2 2025 Aug 13, 2025	SELL	$1.55 - $3.97 $13,950 - $35,730	-9,000 Reduced 64.29%	5,000 $18,000
Q1 2025 May 12, 2025	BUY	$1.69 - $2.84 $21,209 - $35,642	12,550 Added 865.52%	14,000 $26,000
Q4 2024 Jun 06, 2025	SELL	$1.26 - $2.13 $9,513 - $16,081	-7,550 Reduced 53.93%	6,450 $11,000
Q4 2024 Feb 07, 2025	SELL	$1.26 - $2.13 $3,780 - $6,390	-3,000 Reduced 67.42%	1,450 $2,000
Q3 2024 Nov 13, 2024	SELL	$0.94 - $1.55 $96 - $159	-103 Reduced 2.26%	4,450 $5,000
Q2 2024 Aug 13, 2024	BUY	$0.86 - $1.63 $2,420 - $4,586	2,814 Added 161.82%	4,553 $4,000
Q1 2024 May 10, 2024	BUY	$1.27 - $2.24 $1,270 - $2,240	1,000 Added 135.32%	1,739 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.25 - $0.58 $56 - $129	-224 Reduced 23.26%	739 $0
Q3 2021 Nov 05, 2021	SELL	$2.35 - $3.88 $28,418 - $46,920	-12,093 Reduced 92.62%	963 $3,000
Q1 2021 May 13, 2021	BUY	$2.92 - $5.06 $292 - $505	100 Added 0.77%	13,056 $45,000
Q4 2020 Feb 10, 2021	BUY	$2.22 - $3.78 $25,072 - $42,691	11,294 Added 679.54%	12,956 $36,000
Q3 2020 Nov 12, 2020	SELL	$2.39 - $13.08 $5,370 - $29,390	-2,247 Reduced 57.48%	1,662 $4,000
Q2 2020 Aug 14, 2020	SELL	$6.67 - $13.58 $53,159 - $108,232	-7,970 Reduced 67.09%	3,909 $53,000
Q1 2020 May 18, 2020	BUY	$4.1 - $10.24 $48,703 - $121,640	11,879 New	11,879 $90,000

Others Institutions Holding AKBA

# of Institutions

176

Shares Held

106M

Call Options Held

134K

Put Options Held

262K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $388M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Akebia Therapeutics, Inc. Transaction History